I wonder how Novartis is dealing with Mesoblast now? Who has the upper hand?
NVS - sign here and give your IP away for cheap - you are running out of money anyway
SI - well look at this we have SurgCentre investment
NVS - we are going to hold this up until you get some directions from the FDA
SI - ok, but it will cost you more later - we are going to move on with our next indication CLBP and then the other indications. Do you think there are other pharmas who may be interested in CHF? Dr Perin is almost ready to publish his journal - hmmmm
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-54
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |